Literature DB >> 15734967

Surveillance patterns and polyp recurrence following diagnosis and excision of colorectal polyps in a medicare population.

Mayur M Amonkar1, Timothy L Hunt, Zhiyuan Zhou, Xiaodong Jin.   

Abstract

OBJECTIVE: Study objectives were to determine surveillance and polyp recurrence rates among older, increased-risk patients who have been diagnosed and excised of colorectal polyps. The high incidence of colorectal cancers in the Medicare-eligible population, the strong evidence linking reductions in mortality from colorectal cancer by removal of colorectal polyps, and the paucity of postpolypectomy surveillance data in this population all supported the need for this study.
METHODS: This retrospective study used Medicare claims data to identify a cohort of 19,895 beneficiaries ages >/=65 years diagnosed and excised of colorectal polyps in 1994. Survival analysis was used to compute surveillance and polyp recurrence rates over 5 years. Log-rank test was used for all statistical comparisons.
RESULTS: Median time to first surveillance was 2.6 years. Surveillance rates for 1, 3, and 5 years were 17.6%, 55.8%, and 74.5%, respectively. Twenty-six percent had no surveillance event. Polyp recurrence rates for 1, 3, and 5 years were 10.9%, 38.2%, and 52.6%, respectively. Males and younger patients were more likely to undergo surveillance and showed higher polyp recurrence rates.
CONCLUSIONS: The high likelihood of polyp recurrence underscores the need for continued efforts to promote awareness of and compliance with postpolypectomy surveillance. Efforts to increase surveillance rates among individuals diagnosed with colorectal polyps and making available additional treatment options that may prevent the recurrence of polyps and/or their possible progression to colorectal cancer should help make significant progress in reaching the Healthy People 2010 goal of reducing colorectal cancer deaths by 34% by the year 2010.

Entities:  

Mesh:

Year:  2005        PMID: 15734967     DOI: 10.1158/1055-9965.EPI-04-0342

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

1.  Screening colonoscopy among colorectal cancer survivors insured by Medicaid.

Authors:  Kristie Long Foley; Eun-Young Song; Heidi Klepin; Ann Geiger; Janet Tooze
Journal:  Am J Clin Oncol       Date:  2012-06       Impact factor: 2.339

2.  Clinicopathological features of colon polyps from African-Americans.

Authors:  Mehdi Nouraie; Fatemeh Hosseinkhah; Hassan Brim; Behrouz Zamanifekri; Duane T Smoot; Hassan Ashktorab
Journal:  Dig Dis Sci       Date:  2010-03-12       Impact factor: 3.199

3.  Risk of colorectal adenomas in women with prior breast cancer.

Authors:  Ashish Shukla; Sandhya Shukla; Ayodele Osowo; Terry Mashtare; Manoop S Bhutani; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2012-10-12       Impact factor: 3.199

4.  The impact of fair colonoscopy preparation on colonoscopy use and adenoma miss rates in patients undergoing outpatient colonoscopy.

Authors:  Stacy B Menees; H Myra Kim; Eric E Elliott; Jennifer L Mickevicius; Brittany B Graustein; Philip S Schoenfeld
Journal:  Gastrointest Endosc       Date:  2013-04-30       Impact factor: 9.427

5.  Utilization of surveillance after polypectomy in the medicare population--a cohort study.

Authors:  Iris Lansdorp-Vogelaar; Stacey Fedewa; Chun Chieh Lin; Katherine S Virgo; Ahmedin Jemal
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

6.  A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy.

Authors:  Shubhashish Sarkar; Vsevolod L Popov; Malaney R O'Connell; Heather L Stevenson; Brian S Lee; Robert A Obeid; Gurinder K Luthra; Pomila Singh
Journal:  Lab Invest       Date:  2017-04-17       Impact factor: 5.662

7.  Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems.

Authors:  Jessica Chubak; Dale McLerran; Yingye Zheng; Amit G Singal; Douglas A Corley; V Paul Doria-Rose; Chyke A Doubeni; Aruna Kamineni; Jennifer S Haas; Ethan A Halm; Celette Sugg Skinner; Ann G Zauber; Karen J Wernli; Elisabeth F Beaber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-11-20       Impact factor: 4.254

Review 8.  Importance of postpolypectomy surveillance and postpolypectomy compliance to follow-up screening--review of literature.

Authors:  Sri Rapuri; Jeanne Spencer; Dennis Eckels
Journal:  Int J Colorectal Dis       Date:  2008-01-09       Impact factor: 2.796

9.  Adherence to physician recommendations for surveillance in opportunistic colorectal cancer screening: the necessity of organized surveillance.

Authors:  Christian Stock; Bernd Holleczek; Michael Hoffmeister; Thomas Stolz; Christa Stegmaier; Hermann Brenner
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.